Change - Announcement of Appointment::APPOINTMENT OF CHIEF OPERATING OFFICER

Issuer & Securities

Issuer/ Manager
PASTURE HOLDINGS LTD.
Securities
PASTURE HOLDINGS LTD. - SGXE54661850 - UUK
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
01-Nov-2024 19:18:55
Status
New
Announcement Sub Title
APPOINTMENT OF CHIEF OPERATING OFFICER
Announcement Reference
SG241101OTHRTWDZ
Submitted By (Co./ Ind. Name)
Soong Chin Kum Jonathan Lloyd
Designation
Executive Chairman and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Appointment of Chief Operating Officer.

This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Shervyn Essex, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg.

Additional Details

Date Of Appointment
01/11/2024
Name Of Person
TAN XI YI
Age
40
Country Of Principal Residence
Malaysia
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Board of Directors of the Company (the "Board") has reviewed and assessed the relevant professional and academic qualifications, working experience, including his current experience as Head of Business Development of the Group since March 2023, and suitability of Mr Tan Xi Yi ("Mr Tan") and considered the recommendations of the Nominating Committee and that Mr Tan be appointed as Chief Operating Officer ("COO") of the Company. The Board is satisfied that Mr Tan has the requisite experience and capabilities to assume the responsibilities of the COO, and has approved the appointment of Mr Tan as COO.
Whether appointment is executive, and if so, the area of responsibility
Yes. Mr. Tan will support the CEO in implementing strategic initiatives, manage projects and divisions to achieve directors' objectives, shape long-term company goals, identify and execute growth opportunities, develop market relationships, and ensure operational efficiency and regulatory compliance.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Operating Officer
Professional qualifications
- Bachelor of Pharmacy Degree (Honors)
- Registered Pharmacist with Pharmacy Board Malaysia
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
No
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
- Head of Department, Business Development, Pasture Pharma Pte Ltd
March 2023 - Present

- COO, Lucenxia (M) Sdn Bhd
February 2022 - September 2022

- General Manager, Adventa Healthcare (M) Sdn Bhd
January 2020 - February 2023

- Deputy General Manager, Adventa Healthcare (M) Sdn Bhd
January 2019 - December 2019

- Business Development Manager cum Pharmacist (Regulatory), Adventa Healthcare (M) Sdn Bhd
April 2017 - December 2018

- Community Pharmacist cum Branch Manager, KFV Sdn Bhd
December 2011 - March 2017
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Mr Tan holds 40,000 ordinary shares in Pasture Group Holdings Ltd.
Other Principal Commitments* Including Directorships#
*"Principal Commitments" has the same meaning as defined in the Code
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
1. Adventa Healthcare Sdn Bhd : Director
2. Mycare Lanka (Private) Ltd : Director
3. Lucenxia International Sdn Bhd : Director
4. Lucenxia (Thailand) Co. Ltd : Director
5. Lucenxia (M) Sdn Bhd : Director
6. Lucenxia Philippines International Inc : Director
7. Pt Akema Healthcare International : Commissioner
8. Pt Humana Medical International : Commissioner
9. Pt Adventa Biomedical International :Commissioner
10. Adventa Digital Health Sdn Bhd : Director
Present
None
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Disclosure applicable to the appointment of Director only.
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
N/A
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
N/A